Related Experiment Videos
Anaphylactoid reactions to vancomycin during anaesthesia: two clinical reports
Canadian Anaesthetists' Society Journal
|March 1, 1985
Abstract:
Vancomycin is becoming increasingly used for prophylaxis, and treatment against resistant forms of penicillinase-producing staphylococci. This drug, and the aminoglycosides as a group, have serious side-effects and organ toxicity, and may interact with anaesthetic drugs, particularly muscle relaxants. Two cases of anaphylactoid reactions to vancomycin are reported. The first patient subsequently developed oliguria and marked oedema, while the second developed non-cardiogenic pulmonary oedema.
Insights
Vancomycin is increasingly used for bacterial infections. However, this antibiotic can cause severe anaphylactoid reactions and organ toxicity, necessitating careful monitoring.
Area of Science:
- Pharmacology
- Infectious Diseases
- Critical Care Medicine
Background:
- Vancomycin is a critical antibiotic for treating infections caused by penicillinase-producing staphylococci.
- Increasing use of vancomycin for prophylaxis and treatment necessitates understanding its adverse effects.
Observation:
- Two cases of anaphylactoid reactions to vancomycin are presented.
- These reactions occurred in patients receiving vancomycin for staphylococcal infections.
Findings:
- The first patient experienced oliguria and significant edema post-reaction.
- The second patient developed non-cardiogenic pulmonary edema following vancomycin administration.
Implications:
- Vancomycin, despite its efficacy, carries risks of severe adverse events, including anaphylaxis and organ damage.
- Clinicians must be vigilant for vancomycin toxicity, especially in patients with comorbidities or those on concurrent medications like anesthetics.